期刊文献+

糖尿病大鼠纹状体、海马区帕金森病相关蛋白的蛋白质组学初步研究 被引量:4

Proteomic Analysis of Proteins Related to Parkinson's Disease in the Corpus Striatum and Hippocampus of Diabetes Rat Model
原文传递
导出
摘要 为解释糖尿病型帕金森病的分子机理,利用LC-ESI-TOF与LC-ESI-MS/MS联用的比较蛋白质组学方法,分析了链脲霉素诱导的糖尿病大鼠模型与对照大鼠的纹状体、海马区蛋白的表达差异,通过定量比较发现有23种蛋白表达水平发生了2倍以上的显著变化。其中包括与帕金森病致病通路(兴奋性中毒)密切相关的兴奋性氨基酸转运蛋白,与自由基清除、氧化应激密切相关的超氧化物歧化酶,以及与能量合成密切相关的线粒体ATP合酶。发现参与糖酵解过程的7种酶也发生了不同程度的表达变化,提示可能与内源性神经毒素1-乙酰基-6,7-二羟基-1,2,3,4-四氢异喹啉的生成与累积密切相关。 Diabetes is a risk factor for Parkinson' s disease (PD). There are statistics data indicating that the prevalence of PD among patients with diabetes was higher compared with the normal people. To date, little is known about the molecular events underlying hyperglycemia-induced PD. Here, the proteins of corpus striatum (ST) and hippocampus from the brains of diabetes rat models and control rats were analyzed by comparing proteomics method. LC-ESI-TOF and LC- ESI-MS/MS were used for analysis. It was found that 23 express levels of proteins, in which including excitatory amino acid transporter, ATP synthase and superoxide dismutase (SOD), were significantly changed in the experiments. It was also found that seven key enzymes which occurred in glycolysis pathway increased significantly in diabetes rat model brains, which mean that the endogenous neurotoxin ADTIQ concentration perhaps had been enhanced. These results indicated that the express levels of several proteins close related to PD which changed under hyperglycemia condition, and it supports the view that diabetes is a risk factor for Parkinson's disease.
出处 《化学通报》 CAS CSCD 北大核心 2008年第6期430-434,共5页 Chemistry
基金 国家自然科学基金项目(20435020)资助
关键词 糖尿病 帕金森病蛋白质组 1-乙酰基-6 7-二羟基-1 2 3 4-四氢异喹啉 Diabetes, Parkinson's disease, Proteomics, ADTIQ
  • 相关文献

参考文献13

  • 1T Annanmaki, A Pessala-Driver, L Hokkanen et al. Parkinsonism Relat Disord,, 2008, (3) :1 - 3,
  • 2G Hu, P Jousilahti, S Bidel et al. Diabetes Care, 2007, (40) : 842 - 847.
  • 3徐叔云 卞如濂 陈修.药理实验方法学[M].北京:人民卫生出版社,2003.226-258.
  • 4J D Braunstein, M Halwer. Clin Chem., 1986, 32(8):1588 - 1589.
  • 5D W Song, Q Li, Y J Luan et al. Complex Medical Engineering, 2007. CME 2007. IEEE/ICME Intl, Conf. on 23-27. 2007:1817 - 1823,
  • 6C W Olanow. Mov. Disord,, 2007, (17) : 335 - 342.
  • 7S Li, M Mallory, M Alford et al. J. Neuropathol. Exp. Neurol,, 1997, 56(8) :901 - 911.
  • 8K S Saravanan, K M Sindhu, K P Mohanakumar, J, Pineal, Res., 2007, 42(3) :247 - 253.
  • 9Y Han, E Randell, S Vasdev et al. Mol. Cell. Biochem., 2007, 305(1-2):123 -131.
  • 10Y L Deng, A M Rajput. 126th Annual Meeting, American Neurological Association. Annals of Neurology. 2001 ;A15 - 16.

共引文献27

同被引文献36

  • 1郭丽萍,王坚,蒋雨平.胰岛素受体磷酸化增加对MPP^+诱导的PC12细胞凋亡的影响[J].中国临床神经科学,2006,14(2):146-153. 被引量:5
  • 2蒲丽君,黄颂敏.血管紧张素IV/AT4受体系统研究进展[J].国际泌尿系统杂志,2006,26(2):283-287. 被引量:2
  • 3Zhang ZX, Anderson DW, Huang JB, et al. Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China [ J ]. Movement Disorders, 2003, 18 (7): 764-772.
  • 4Pressley JC, Louis ED, Tang MX, et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism [J]. Neurology, 2003, 60: 87-93.
  • 5Smith .IL, Ju JS, Saha BM, et al. Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin -stimulated glucose transport in rat skeletal muscle[J].J Appl Physiol, 2004, 97: 2339 - 2346.
  • 6Arvanitakis Z, Wilson RS, Schneider JA, et al. diabetes mellitus and progression of rigidity and gait disturbance in older persons [J]. Neurology, 2004, 63: 996-1001.
  • 7Gang Hu, Pekka, Siamak, et al. Type 2 diabetes and the risk of parkinson's disease[J]. Diabetes Care, 2007, 30: 842-847.
  • 8Wilson RS, Schneider JA, Bienias LL, et al. Parkinsonian - like signs and risk of incident Mzheimer disease in older persons [J]. Arch Neurol, 2003, 60:539 -544.
  • 9Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes [ J ]. Dia betes, 2004, 53 (Suppl1): S110-118.
  • 10Owen AM, Doyon J, Dagher A, et al. Abnormal basal ganglia outflow in Parkinson' disease identified with PET implications for higher cortical functions [ J]. Brain, 1998, 121: 949 - 965.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部